Stefania Koutsilieri

Publikationer
Populärvetenskap och samverkan

Artiklar

Article: BIOTECHNOLOGY JOURNAL. 2024;19(3):e2300684
Proteomic workflows for deep phenotypic profiling of 3D organotypic liver models
Koutsilieri S; Mickols E; Vegvari A; Lauschke VM
Article: NATURE COMMUNICATIONS. 2023;14(1):6243
GLP-1R signaling neighborhoods associate with the susceptibility to adverse drug reactions of incretin mimetics
Wright SC; Motso A; Koutsilieri S; Beusch CM; Sabatier P; Berghella A; Blondel-Tepaz E; Mangenot K; Pittarokoilis I; Sismanoglou D-C; Le Gouill C; Olsen JV; Zubarev RA; Lambert NA; Hauser AS; Bouvier M; Lauschke VM
Article: ACS CHEMICAL BIOLOGY. 2023;18(9):1993-2002
Tacrine First-Phase Biotransformation and Associated Hepatotoxicity: A Possible Way to Avoid Quinone Methide Formation
Novak M; Vajrychova M; Koutsilieri S; Sismanoglou D-C; Kobrlova T; Prchal L; Svobodova B; Korabecny J; Zarybnicky T; Raisova-Stuchlikova L; Skalova L; Lauschke VM; Kucera R; Soukup O
Article: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 2022;148(12):3293-3302
CFTR reduces the proliferation of lung adenocarcinoma and is a strong predictor of survival in both smokers and non-smokers
Xiao Q; Koutsilieri S; Sismanoglou D-C; Lauschke VM
Article: PHARMACOLOGICAL RESEARCH. 2020;153:104590
Unveiling the guidance heterogeneity for genome-informed drug treatment interventions among regulatory bodies and research consortia
Koutsilieri S; Tzioufa F; Sismanoglou D-C; Patrinos GP
Article: HUMAN GENOMICS. 2020;14(1):4
Delineating significant genome-wide associations of variants with antipsychotic and antidepressant treatment response: implications for clinical pharmacogenomics
Koromina M; Koutsilieri S; Patrinos GP
Article: FRONTIERS IN PHARMACOLOGY. 2019;10:830
Application of Economic Evaluation to Assess Feasibility for Reimbursement of Genomic Testing as Part of Personalized Medicine Interventions
Simeonidis S; Koutsilieri S; Vozikis A; Cooper DN; Mitropoulou C; Patrinos GP
Journal article: CHEST. 2012;142(4):1080a-1080c
Cross-Workshift Changes in Lung Function Parameters in Hospitality Workers With Workplace SHS Exposures
Neophytou A; Anagnostopoulos N; Vardavas C; Koutsilieri S; Dotis G; Evangelopoulou V; Laden F; Behrakis P; Dockery D

Alla övriga publikationer

Review: BASIC AND CLINICAL PHARMACOLOGY AND TOXICOLOGY. 2022;131(6):452-464
A paradigm shift in pharmacogenomics: From candidate polymorphisms to comprehensive sequencing
Zhou Y; Koutsilieri S; Eliasson E; Lauschke VM
Editorial comment: JCO ONCOLOGY PRACTICE. 2020;16(12):799-800
Genome-Guided Reassurance of Drug Safety in Cancer Therapy: The Paradigm of Fluorouracil
Koutsilieri S; Patrinos GP
Editorial comment: PHARMACOLOGICAL RESEARCH. 2020;158:104839
Towards harmonizing guidance for genome-informed drug treatment interventions: The show must go on
Koutsilieri S; Tzioufa F; Sismanoglou D-C; Patrinos GP
Editorial comment: AMERICAN JOURNAL OF HEMATOLOGY. 2019;94(7):737-740
Optimizing thiopurine dosing based on TPMT and NUDT15 genotypes: It takes two to tango
Koutsilieri S; Caudle KE; Alzghari SK; Monte AA; Relling MV; Patrinos GP

Artiklar

Alla övriga publikationer

Nyheter från KI

Kalenderhändelser från KI